PTPRC and neoplasm: The results revealed that EE elevated the β1-AR and β3-AR mRNA expression levels in CD45- (mostly tumor cells), CD45+ (immune cells) (Supplementary Fig. 5F), TAMs (Supplementary Fig. 5G), and G-MDSCs (Supplementary Fig. 5H).